IFNA1 and HIV-1 infection: On one hand, the activation of IFN genes in the acute phase of HIV-1 infection may benefit initial immune responses [35] and it has indeed been associated with protection from HIV-1 acquisition in a recent systems vaccinology study on the RV144 vaccine clinical trial [36].